{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T18:43:25Z","timestamp":1782758605537,"version":"3.54.5"},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2020,3,31]]},"DOI":"10.18632\/oncotarget.27528","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T13:56:46Z","timestamp":1586181406000},"page":"1141-1156","source":"Crossref","is-referenced-by-count":34,"title":["Synergistic cytotoxic activity of cannabinoids from<i>cannabis sativa<\/i>against cutaneous T-cell lymphoma (CTCL)<i>in-vitro<\/i>and<i>ex-vivo<\/i>"],"prefix":"10.18632","volume":"11","author":[{"given":"Moran","family":"Mazuz","sequence":"first","affiliation":[{"name":"Agricultural Research Organization (ARO), Volcani Center, Rishon LeZion, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Tiroler","sequence":"additional","affiliation":[{"name":"Agricultural Research Organization (ARO), Volcani Center, Rishon LeZion, Israel"},{"name":"The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach","family":"Moyal","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Laboratory for Molecular Dermatology, Felsenstein Medical Research Center, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmilia","family":"Hodak","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Laboratory for Molecular Dermatology, Felsenstein Medical Research Center, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stalin","family":"Nadarajan","sequence":"additional","affiliation":[{"name":"Agricultural Research Organization (ARO), Volcani Center, Rishon LeZion, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajjampura C.","family":"Vinayaka","sequence":"additional","affiliation":[{"name":"Agricultural Research Organization (ARO), Volcani Center, Rishon LeZion, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batia","family":"Gorovitz-Haris","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Dermatology, Felsenstein Medical Research Center, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Lubin","sequence":"additional","affiliation":[{"name":"Core Facility, Felsenstein Medical Research Center, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Drori","sequence":"additional","affiliation":[{"name":"MedC Biopharma Corporation, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Drori","sequence":"additional","affiliation":[{"name":"MedC Biopharma Corporation, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen Van","family":"Cauwenberghe","sequence":"additional","affiliation":[{"name":"AgMedica Bioscience Inc., Chatham-Kent, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Faigenboim","sequence":"additional","affiliation":[{"name":"Agricultural Research Organization (ARO), Volcani Center, Rishon LeZion, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dvora","family":"Namdar","sequence":"additional","affiliation":[{"name":"Agricultural Research Organization (ARO), Volcani Center, Rishon LeZion, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Amitay-Laish","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Laboratory for Molecular Dermatology, Felsenstein Medical Research Center, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinanit","family":"Koltai","sequence":"additional","affiliation":[{"name":"Agricultural Research Organization (ARO), Volcani Center, Rishon LeZion, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1663\/0013-0001(2003)057[0295:AEFTTO]2.0.CO;2","article-title":"Archaeological evidence for the tradition of psychoactive plant use in the old world","volume":"57","author":"Merlin","year":"2003","journal-title":"Econ Bot"},{"key":"2","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Gallily","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1039\/C6NP00074F","article-title":"Phytocannabinoids: a unified critical inventory","volume":"33","author":"Appendino","year":"2016","journal-title":"Nat Prod Rep"},{"key":"4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1021\/acs.jnatprod.5b00949","article-title":"Evolution of the cannabinoid and terpene content during the growth of Cannabis sativa plants from different chemotypes","volume":"79","author":"Usobiaga","year":"2016","journal-title":"J Nat Prod"},{"key":"5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s11101-008-9094-4","article-title":"Secondary metabolism in cannabis","volume":"7","author":"Verpoorte","year":"2008","journal-title":"Phytochem Rev"},{"key":"6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CBand CB","volume":"62","author":"Ross","year":"2010","journal-title":"Pharmacol Rev"},{"key":"7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Zimmer","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"8","doi-asserted-by":"publisher","first-page":"33896","DOI":"10.1074\/jbc.M303994200","article-title":"The endocannabinoid system in human keratinocytes: evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activating protein-1, and transglutaminase","volume":"278","author":"Finazzi-Agr\u00f2","year":"2003","journal-title":"J Biol Chem"},{"key":"9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Casellas","year":"1995","journal-title":"Eur J Biochem"},{"key":"10","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1124\/mol.107.042945","article-title":"Analysis of promoter regions regulating basal and interleukin-4-inducible expression of the human CB1 receptor gene in T lymphocytes","volume":"73","author":"Kraus","year":"2008","journal-title":"Mol Pharmacol"},{"key":"11","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Jaffe","year":"2019","journal-title":"Blood"},{"key":"12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.beha.2018.07.007","article-title":"Integrating novel systemic therapies for the treatment of mycosis fungoides and S\u00e9zary syndrome","volume":"31","author":"Querfeld","year":"2018","journal-title":"Best Pract Res Clin Haematol"},{"key":"13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaad.2013.07.049","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and S\u00e9zary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers","volume":"70","author":"Querfeld","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"key":"14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2016.02.010","article-title":"Cannabinoid pharmacology in cancer research: A new hope for cancer patients","volume":"775","author":"Ligresti","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fphar.2016.00361","article-title":"Preclinical and clinical assessment of cannabinoids as anti-cancer agents","volume":"7","author":"Van Dross","year":"2016","journal-title":"Front Pharmacol"},{"key":"16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3892\/ijo.2017.4022","article-title":"Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration","volume":"51","author":"Liu","year":"2017","journal-title":"Int J Oncol"},{"key":"17","first-page":"4373","article-title":"Enhancing the activity of cannabidiol and other cannabinoidsthrough modifications to drug combinations and treatment schedules","volume":"33","author":"Liu","year":"2013","journal-title":"Anticancer Res"},{"key":"18","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3389\/fpls.2018.01969","article-title":"The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No \u201cStrain,\u201d No Gain","volume":"9","author":"Russo","year":"2019","journal-title":"Front Plant Sci"},{"key":"19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1089\/can.2018.0010","article-title":"Identification of synergistic interaction between cannabis-derived compounds for cytotoxic activity in colorectal cancer cell lines and colon polyps that induces apoptosis-related cell death and distinct gene expression","volume":"3","author":"Koltai","year":"2018","journal-title":"Cannabis Cannabinoid Res"},{"key":"20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1365-2133.2001.04014.x","article-title":"The relevance of the CD4+ CD26\u2013subset in the identification of circulating S\u00e9zary cells","volume":"144","author":"Fierro","year":"2001","journal-title":"Br J Dermatol"},{"key":"21","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.3747\/co.23.3080","article-title":"Anticancer mechanisms of cannabinoids","volume":"23","author":"Guzm\u00e1n","year":"2016","journal-title":"Curr Oncol"},{"key":"22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ccr.2006.03.005","article-title":"The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells","volume":"9","author":"Velasco","year":"2006","journal-title":"Cancer Cell"},{"key":"23","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/ijc.23584","article-title":"Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation","volume":"123","author":"Sander","year":"2008","journal-title":"Int J Cancer"},{"key":"24","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1038\/sj.leu.2403057","article-title":"High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma","volume":"17","author":"Sander","year":"2003","journal-title":"Leukemia"},{"key":"25","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Denovan-Wright","year":"2015","journal-title":"Br J Pharmacol"},{"key":"26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2008.302","article-title":"Signaling cross-talk between TGF-\u03b2\/BMP and other pathways","volume":"19","author":"Wang","year":"2009","journal-title":"Cell Res"},{"key":"27","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1053\/hupa.2000.20370","article-title":"Constitutive expression of NF-\u03baB is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis","volume":"31","author":"Alkan","year":"2000","journal-title":"Hum Pathol"},{"key":"28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bbrc.2006.12.177","article-title":"RRM2 induces NF-\u03baB-dependent MMP-9 activation and enhances cellular invasiveness","volume":"354","author":"Whang","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"29","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Ribas","year":"2010","journal-title":"Nature"},{"key":"30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1101\/gad.14.5.521","article-title":"The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development","volume":"14","author":"Kohwi-Shigematsu","year":"2000","journal-title":"Genes Dev"},{"key":"31","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.celrep.2017.04.038","article-title":"Essential roles of SATB1 in specifying T lymphocyte subsets","volume":"19","author":"Taniuchi","year":"2017","journal-title":"Cell Rep"},{"key":"32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.21873\/anticanres.11006","article-title":"Expression of SATB1, MTI\/II and Ki-67 in mycosis fungoides","volume":"36","author":"Dziegiel","year":"2016","journal-title":"Anticancer Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.jid.2018.03.1526","article-title":"SATB1 in malignant T cells","volume":"138","author":"Buus","year":"2018","journal-title":"J Invest Dermatol"},{"key":"34","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.1073\/pnas.92.16.7307","article-title":"Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes","volume":"92","author":"O\u2019Shea","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1385\/IR:31:3:231","article-title":"STAT4: A critical regulator of inflammation","volume":"31","author":"Kaplan","year":"2005","journal-title":"Immunol Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1182\/blood-2012-08-449140","article-title":"MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor","volume":"121","author":"Bates","year":"2013","journal-title":"Blood"},{"key":"37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/bjh.13065","article-title":"Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphoma","volume":"167","author":"Baiocchi","year":"2014","journal-title":"Br J Haematol"},{"key":"38","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1158\/1078-0432.CCR-14-2034","article-title":"Idelalisib: first-in-class PI3K delta inhibitor for the treatment of chronic lymphocytic leukemia, small lymphocytic leukemia, and follicular lymphoma","volume":"21","author":"Gandhi","year":"2015","journal-title":"Clin Cancer Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nrm.2016.27","article-title":"Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases","volume":"17","author":"Sicinski","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF02631086","article-title":"Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides","volume":"28","author":"Thestrup-Pedersen","year":"1992","journal-title":"Cell Dev Biol Anim"},{"key":"41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1182\/blood.V55.3.409.409","article-title":"Mitogen requirements for thepropagation of cutaneous T-cell","volume":"55","author":"Guccion","year":"1980","journal-title":"Blood"},{"key":"42","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1128\/AAC.48.10.3702-3710.2004","article-title":"Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus","volume":"48","author":"Xiong","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"43","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Ranki","year":"2007","journal-title":"Blood"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T18:46:32Z","timestamp":1666291592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":43,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,3,31]]}},"alternative-id":["27528","32284791"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.27528","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]}}}